GABEX
Price
$5.16
Change
+$0.05 (+0.98%)
Updated
Jun 2 closing price
Net Assets
451.39M
VFIAX
Price
$703.50
Change
+$0.93 (+0.13%)
Updated
Jun 2 closing price
Net Assets
1.6T
Interact to see
Advertisement

GABEX vs VFIAX

Header iconGABEX vs VFIAX Comparison
Open Charts GABEX vs VFIAXBanner chart's image
GABEX vs VFIAX Comparison Chart in %
View a ticker or compare two or three
VS
GABEX vs. VFIAX commentary
Jun 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GABEX is a Buy and VFIAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VFIAX has more cash in the bank: 1.6T vs. GABEX (451M). GABEX pays higher dividends than VFIAX: GABEX (17.45) vs VFIAX (1.02). GABEX was incepted earlier than VFIAX: GABEX (34 years) vs VFIAX (26 years). GABEX (1.41) is less costly to investors than VFIAX (0.04). VFIAX is a more actively managed with annual turnover of: 2.00 vs. GABEX (0.00). GABEX has a lower initial minimum investment than VFIAX: GABEX (1000) vs VFIAX (3000). VFIAX annual gain was more profitable for investors over the last year : 28.07 vs. GABEX (3.69). VFIAX return over 5 years is better than : 81.36 vs. GABEX (-21.02).
GABEXVFIAXGABEX / VFIAX
Total Expense Ratio1.410.043,525%
Annual Report Gross Expense Ratio1.410.043,525%
Fund Existence34 years26 years-
Gain YTD6.29311.20456%
Front LoadN/AN/A-
Min. Initial Investment1000300033%
Min. Initial Investment IRAN/AN/A-
Net Assets451M1.6T0%
Annual Yield % from dividends17.451.021,717%
Returns for 1 year3.6928.0713%
Returns for 3 years-3.1077.58-4%
Returns for 5 years-21.0281.36-26%
Returns for 10 years-54.08262.10-21%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MBOT2.010.03
+1.52%
Microbot Medical
SII133.330.86
+0.65%
Sprott
STZ136.760.51
+0.37%
Constellation Brands
GNPX0.74-0.01
-1.99%
Genprex Inc.
QNST12.14-0.47
-3.73%
QuinStreet